Immunotherapy in the treatment of lymphoma

Relapsed or refractory non-Hodgkin’s lymphomas, especially diffuse large B-cell lymphoma as well as relapsed or refractory Hodgkin lymphomas are hard-to-treat diseases. Patients who do not respond to initial therapy or experience relapse are treated with salvage regimens, and if eligible for aggress...

Descripción completa

Detalles Bibliográficos
Autores principales: Popovic, Lazar S, Matovina-Brko, Gorana, Popovic, Maja, Popovic, Milica, Cvetanovic, Ana, Nikolic, Ivan, Kukic, Biljana, Petrovic, Dragana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246244/
https://www.ncbi.nlm.nih.gov/pubmed/34249225
http://dx.doi.org/10.4252/wjsc.v13.i6.503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246244/
https://www.ncbi.nlm.nih.gov/pubmed/34249225
http://dx.doi.org/10.4252/wjsc.v13.i6.503

Ejemplares similares